パイオニア系 ETV2 は,胚内皮系を特定するためのネットワークを制御する
Satyabrata Das1,2, Xiao Ma1,2, Kidus Hailemariam1
1Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Cardiovascular research
|August 20, 2025
まとめ
転写因子ETV2は,遺伝子発現と表遺伝的変化を調節することによって,血液内皮細胞 (HE) 系統の発達を誘導する. ETV2の過剰発現はHE細胞の生成を促進し,心筋や骨格筋のような他のメソダーマ系を抑制します.
科学分野:
- 発達生物学
- 幹細胞生物学
- 分子遺伝学
背景:
- 細胞数が限られているため,メソダーマの原始細胞の分化を理解することは極めて重要ですが,困難です.
- 転写因子ETV2は,分化と再プログラムの両方に影響を与える血液内皮細胞 (HE) 系統の重要な調節因子である.
- ETV2が細胞運命を決定するトランスクリプションおよび表遺伝的変化を指揮する正確な役割は,まだ完全に理解されていません.
研究 の 目的:
- メソダーマの分化中にETV2によって支配される転写および表皮的メカニズムを解明する.
- ETV2 が HE 系統の発達を促し,同時に代替メソダーマの運命を抑制する方法を調査する.
- HEの原始子系統の決定における ETV2用量の役割を定義する.
主な方法:
- ETV2過剰発現によるマウス胚性幹細胞-胚体 (ES-EB) 微分化システムを使用した.
- 骨格筋,心臓,HE系統から原始細胞を分離するために,光活性化細胞分類 (FACS) を採用した.
- 転写および表遺伝的環境を分析するために,単細胞RNA配列化 (scRNA-seq) とトランポゼアクセシブルクロマチン配列化 (ATAC-seq) を適用した.
主要な成果:
- ETV2の過剰発現は,心臓と骨格筋の系統を犠牲にして HE系統細胞を効率的に生成しました.
- ETV2は心臓の発達を抑制するために,Mesp1のような心臓系の主調節体を直接抑制しました.
- ETV2の直接的なダウンストリームターゲットとしてTlr3とTlr4を特定し,HE系統の開発に不可欠です.
結論:
- ETV2は先駆的な転写因子として機能し,メソダーマの原始細胞をHE系統に導きます.
- ETV2レベルは HEの系統へのコミットメントと代替運命の抑制のバランスを決定的に影響します.
- この研究は,ETV2の規制ネットワークを定義し,HE系統の仕様に関する洞察を提供します.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Determination
19.1K
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
19.1K
Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
Development of Blood Vessels
777
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
777
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K


